Valeant Canada announces substantial investment into its Manitoba plant
Valeant Canada announced an $8 million investment into its Steinbach, Manitoba manufacturing plant for Xifaxan and Apriso.
News & Media
Increased Funding for Intravenous Cancer Drugs Will Support Manitobans Fighting Cancer
The 2016 Provincial budget increases funding to support the provision of cancer drugs for patients across the province by $4 million.
Richard Tyc and Mark Torchia Receive Governor General's Award
The awards were presented May 19, 2016 at Rideau Hall in Ottawa
Tiny microbes, big idea
An exciting update of LSAM member company Exigence Technologies.
Foerster, Torchia to be inducted to St-Boniface Hospital Research Hall of Fame
Drs Foerster and Torchia will be inducted as the 3rd and 4th members of the Hall of Fame.
Funding for SBRC Youth BIOlab
The St. Boniface Hospital’s RBC Youth BIOlab Jeunesse will receive $120,000 over 3 years from the Natural Sciences and Engineering Research Council of Canada (NSERC) ensuring that today's youth are engaged in science from an early age your years to come.
Dr. Mark Torchia And Richard Tyc Receive Canadian Governor General's Innovation Award
NAUGURAL AWARD RECOGNIZES ENTREPRENEURIAL INNOVATION
Cubresa's NuPet PET scanner released for simultaneous PET/MR in existing MR systems
Cubresa Inc. today, announced the release of its NuPET™ scanner.
Kane Biotech Announces bluestem™ Breakthrough Order with Major Retail Chain
Kane Biotech Inc. is pleased to announce that it has received a breakthrough order of its bluestem™ brand of oral care products from a major North American pet specialty store chain.
Creating Jobs and Investment for Canadian Youth - Government of Canada Invests $165 Million in Youth Employment Strategy, Supports Thousands of Youth Across Canada
The Government of Canada is investing over $165 million in the Youth Employment Strategy (YES) starting this year through Budget 2016.
Dr Carla Taylor appointed CCARM team leader
Dr Grant Pierce, Executive Director of Research, St-Boniface Hospital is pleased to announce the appointment of Dr Carla Taylor as Team Leader of the Canadian Centre for Agri-Food Research in Health and Medicine (CCARM), for a 3 year term.
WINNIPEG AGAIN NAMED A ‘TOP7 INTELLIGENT COMMUNITY’ IN GLOBAL COMPETITION
For the second time in three years, Winnipeg has earned a coveted spot on the Intelligent Community Forum’s (ICF) list of the Top7 Intelligent Communities in the world.
Arterial Stiffness Inc. sets sights on China first
Rather than take the conventional route of achieving regulatory approval in Canada and the U.S. and then exporting the technology elsewhere around the world, ASI is going to China first.
Accel-Rx/BDC make second portfolio investment in ScarX Therapeutics
Company completing Phase 1 human clinical trial of drug to prevent dermal scarring
National Microbiology Laboratory at the centre of developing a new vaccine for Zika virus
To date, four Canadians have returned from travels testing positive for the Zika virus and the pressure is on to develop a vaccine in case the mosquito-borne virus develops into a global emergency, says Dr. Gary Kobinger, chief of special pathogens with t
Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options
Audrey Goertzen CPA, CGA will be Kane Biotech’s new CFO, replacing Mark Matthewson CPA, CA.
Manitoba Technology Accelerator Announcing Ambitious Expansion Plans
Launching Start-Up Central District.
Human Pathogens and Toxins Act (HPTA)
On December 1, 2015, the Human Pathogens and Toxins ActExternal Link (HPTA) came into full force.
Cubresa: Local financing and tech support boost fortune of imaging firm
Cubresa Inc., which has a device ready to go to market, just closed a $3.5-million financing deal and hired a Boston-based CEO who's plugged into Cubresa's specialty market.
XiteBio® SoyRhizo® for Soybean: Expanded usage approval received from CFIA
XiteBio Technologies Inc. is pleased to announce that it has received the approval for expanded use of XiteBio® SoyRhizo® in the Canadian market from the Canadian Food Inspection Agency (CFIA).
BioTalent Canada: New Project Helps Canadians with Disabilities Land a Job in Biotechnology
BioTalent Canada's new program will provide over $1 million in wage subsidies to assist 90 Canadians with disabilities land a job in the country’s biotechnology industry.